Font:
SE

SENORES / NSE / Biotechnology & Drugs

Senores Pharmaceuticals

INR 1,405.15.80 (-3.68%) 1D
Last updated: 2026-07-20T14:43:32.635355+00:00
Price Chart

1Y Price Trend

Open622
High1,509.8
Low601.1
Close1,387.5
Volume1,69,015
Change765.5
Change %123.07%

Key Information

Ticker SymbolSENORES
Current Price1,405.1
52-Week High1,509.8
52-Week Low601.1
Market Cap6,445.43
Volume1,69,015
ISININE0RB801010
Day High1,414.3
Day Low1,380.4
Open1,395

Recommendations

RatingStrong Buy

Target High1,509.2

Target Low601.3

Target Mean1.5

Target Median62.5

Risk Metrics

Overall RiskBalanced risk

Board Risk44.3

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app
News

Latest stock news

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 19 February 20265 months ago
Market news

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — Senores Pharmaceuticals, ELGI Equipments, Lumax AutoTechnologies, Acutaas Chemicals, and Azad Engineering.

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 15 December 20257 months ago
Market news

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today - Indo Borax and Chemicals, Atlanta Electricals, Zota Health Care, CCL Products (India), and Senores Pharmaceuticals.

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 1 December 20257 months ago
Market news

Sumeet Bagadia recommends five breakout stocks to buy today - Acutaas Chemicals, Senores Pharmaceuticals, Latent View Analytics, Zaggle Prepaid Ocean Services, and Dr. Agarwal's Health Care.

Breakout stocks to buy or sell: Sumeet Bagadia recommends three shares to buy today — 21 November 20258 months ago
Market news

Sumeet Bagadia recommends five breakout stocks to buy on Friday, 21 November 2025 — Anand Rathi Share and Stock Brokers, Anupam Rasayan India, Azad Engineering, Senores Pharmaceuticals, and PDS.

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 27 October 20258 months ago
Market news

Sumeet Bagadia recommends five breakout stocks to buy today: Garware Hi-Tech Films, Cholamandalam Financial Holdings, CreditAccess Grameen, Senores Pharmaceuticals, and Bhageria Industries.

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 9 October 20259 months ago
Market news

Sumeet Bagadia recommends five breakout stocks to buy today: Yatharth Hospital & Trauma Cre Srvcs, Remsons Industries, SeQuent Scientific, SRM Contractors, and Senores Pharmaceuticals.

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 3 October 20259 months ago
Market news

Sumeet Bagadia recommends five breakout stocks to buy today: Lumax AutoTechnologies, Senores Pharmaceuticals, Bharat Seats, Rategain Travel Technologies, and Gabriel India.

Senores Pharma share price hits record high rising 13% on Q1 results 2025. Doubles allottees' money in seven months12 months ago
Market news

Senores Pharmaceuticals shares opened at ₹ 648 per share on Thursday, as compared to previous close of ₹ 608.95 on Wednesday.

FAQ

Stock FAQs

What is the symbol and ISIN of Senores Pharmaceuticals?

Senores Pharmaceuticals has the symbol SENORES and ISIN - INE0RB801010.

What is the current price of Senores Pharmaceuticals?

Senores Pharmaceuticals is currently trading at INR 1,405.10.

What are the year high and year low of Senores Pharmaceuticals?

Senores Pharmaceuticals has a year high of INR 1,509.20 and a year low of INR 601.30.

What is the market capitalization of Senores Pharmaceuticals?

Senores Pharmaceuticals has a market capitalization of INR 6,445.43 crore.

What is the P/E ratio of Senores Pharmaceuticals?

Senores Pharmaceuticals has a P/E ratio of 28.78.

What is the dividend yield of Senores Pharmaceuticals?

Senores Pharmaceuticals has a dividend yield of 0.00%.

How is the financial performance of Senores Pharmaceuticals based on revenue, net income, and EPS?

Senores Pharmaceuticals has revenue of INR 6,326.30 crore, net income of INR 1,153.80 crore, and EPS of INR 26.39.

What is the book value of Senores Pharmaceuticals?

Senores Pharmaceuticals has a book value of NA.

What is the debt-to-equity ratio of Senores Pharmaceuticals?

Senores Pharmaceuticals has a debt-to-equity ratio of NA.

What are the price-to-book and price-to-sales ratios of Senores Pharmaceuticals?

Senores Pharmaceuticals has a price-to-book ratio of NA and a price-to-sales ratio of 1.02.